PHASE 1 TRIAL OF RUXOLITINIB, TEMOZOLOMIDE, AND RADIATION IN HIGH-GRADE GLIOMAS

被引：0
|
作者：
Ahluwalia, Manmeet [1 ]
Khosla, Atulya [1 ]
Rauf, Yasmeen [2 ]
Murphy, Erin [3 ]
Chao, Samuel [3 ]
Suh, John [4 ]
Stevens, Glen [5 ]
Peereboom, David [6 ]
机构：
[1] Miami Canc Inst, Baptist Hlth South Florida, Miami, FL USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH USA
[5] Cleveland Clin, Cleveland, OH USA
[6] Richard Jacobs Hlth Ctr, Cleveland Clin, Cleveland, OH USA
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTIM-16
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [41] A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report
    Wakabayashi, Toshihiko
    Kayama, Takamasa
    Nishikawa, Ryo
    Takahashi, Hiroshi
    Hashimoto, Naoya
    Takahashi, Jun
    Aoki, Tomokazu
    Sugiyama, Kazuhiko
    Ogura, Masatoshi
    Natsume, Atsushi
    Yoshida, Jun
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 104 (02) : 573 - 577
  • [42] A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report
    Toshihiko Wakabayashi
    Takamasa Kayama
    Ryo Nishikawa
    Hiroshi Takahashi
    Naoya Hashimoto
    Jun Takahashi
    Tomokazu Aoki
    Kazuhiko Sugiyama
    Masatoshi Ogura
    Atsushi Natsume
    Jun Yoshida
    [J]. Journal of Neuro-Oncology, 2011, 104 : 573 - 577
  • [43] Efficacy of Cisplatin Combined with Temozolomide in the Treatment of Recurrent High-grade Gliomas
    Sun, Yu
    Han, Q. L.
    Lang, X. D.
    Chu, Y. S.
    Liang, J. J.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (01) : S27 - S27
  • [44] Temozolomide and radiotherapy as first-line treatment of high-grade gliomas
    Corsa, Pietro
    Parisi, Salvatore
    Raguso, Arcangela
    Troiano, Michele
    Perrone, Antonio
    Cossa, Sabrina
    Munafo, Tindara
    Piombino, Michele
    Spagnoletti, Girolamo
    Borgia, Francesco
    [J]. TUMORI, 2006, 92 (04) : 299 - 305
  • [45] SAFETY AND EFFICACY OF ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
    Lolli, Ivan
    Divella, Rosa
    Manzillo, Elvira Foglia
    Ercolino, Letizia
    Ronco, Michele
    Troccoli, Vito
    Occhiogrosso, Giuseppe
    Troccoli, Giuseppe
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 86 - 86
  • [46] Re-challenge with temozolomide (TMZ) at recurrence in high-grade gliomas
    Hau, P.
    Pascher, C.
    Beier, C.
    Beier, D.
    Dudel, C.
    Grauer, O.
    Hirschmann, B.
    Mueller, C.
    Reinert, C.
    Wismeth, C.
    Bogdahn, U.
    [J]. ONKOLOGIE, 2008, 31 : 76 - 76
  • [47] A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomas
    Panetta, JC
    Kirstein, MN
    Gajjar, AJ
    Nair, G
    Fouladi, M
    Stewart, CF
    [J]. MATHEMATICAL BIOSCIENCES, 2003, 186 (01) : 29 - 41
  • [48] CYTOPENIAS IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS RECEIVING RADIATION AND TEMOZOLOMIDE-WHO IS AT RISK?
    Mrugala, M. M.
    Johnston, S. K.
    Chamberlain, M. C.
    San, J. V.
    Rockhill, J. K.
    Haug, J.
    Spence, A. M.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1120 - 1120
  • [49] Iatrogenic immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide: A NABTT CNS Consortium study
    Grossman, S. A.
    Ye, X.
    Lesser, G. J.
    Sloan, A. E.
    Carson, C.
    Piantadosi, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas
    Fine, HA
    Wen, PY
    Maher, EA
    Viscosi, E
    Batchelor, T
    Lakhani, N
    Figg, WD
    Purow, BW
    Borkowf, CB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2299 - 2304
12345